Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.500
+0.120 (5.04%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Sonoma Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
44351215
Upgrade
Market Cap Growth
10.94%36.33%-42.82%-63.48%-19.48%77.22%
Upgrade
Enterprise Value
2-212512
Upgrade
Last Close Price
2.382.193.3319.5380.20148.60
Upgrade
PS Ratio
0.240.250.200.340.980.83
Upgrade
PB Ratio
1.200.800.420.571.432.88
Upgrade
P/TBV Ratio
1.260.800.420.571.432.88
Upgrade
EV/Sales Ratio
0.14-0.050.180.410.64
Upgrade
Debt / Equity Ratio
0.190.070.100.110.160.50
Upgrade
Net Debt / Equity Ratio
-0.56-1.15-0.41-0.37-0.69-0.29
Upgrade
Net Debt / EBITDA Ratio
0.731.420.560.671.060.48
Upgrade
Net Debt / FCF Ratio
0.5130.171.050.461.380.43
Upgrade
Asset Turnover
1.301.000.820.760.751.26
Upgrade
Inventory Turnover
3.203.132.873.193.335.12
Upgrade
Quick Ratio
1.211.911.691.781.721.77
Upgrade
Current Ratio
2.883.093.373.712.823.18
Upgrade
Return on Equity (ROE)
-81.19%-65.55%-68.51%-61.79%-72.35%-84.01%
Upgrade
Return on Assets (ROA)
-12.67%-16.31%-18.97%-16.29%-21.75%-14.59%
Upgrade
Return on Capital Employed (ROCE)
-29.40%-38.70%-42.70%-36.50%-45.20%-31.60%
Upgrade
Earnings Yield
-77.89%-97.70%-186.28%-113.48%-40.92%-25.59%
Upgrade
FCF Yield
-85.96%-4.75%-92.47%-141.46%-35.28%-23.04%
Upgrade
Buyback Yield / Dilution
-60.61%-172.75%-168.12%-27.93%-32.92%-35.14%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.